Evidence map›Paper›PMID 40755022›Full record

ArticleFuture microbiology2025

Control of

Anmol Kulshrestha, Pratima Gupta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anmol KulshresthaDepartment of Biotechnology, National Institute of Technology Raipur, Raipur, India.ORCID 0000-0003-2257-6687
Pratima GuptaDepartment of Biotechnology, National Institute of Technology Raipur, Raipur, India.ORCID 0000-0001-7651-1040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimMicrobial biofilms, particularly polymicrobial ones formed by MATERIALS &

methodsBiofilm formation was studied using a Biofilm Infection Simulator System and polymethylmethacrylate coupons. Biofilms were analyzed under untreated and 4-HPA-treated conditions. SAP5 proteinase activity on BSA was quantified in treated & un-treated cultures.

results4-HPA treatment significantly restricted

conclusions4-HPA effectively reduces biofilm formation and SAP5 activity, highlighting its potential as a biofilm-specific therapeutic for polymicrobial infections.

Indexed as

Aspartic Acid EndopeptidasesBiofilmsCandida albicansFungal ProteinsPhenylacetatesStaphylococcus aureusHyphaeAspartic Acid EndopeptidasesFungal ProteinsPhenylacetatesSAP5 protein, Candida albicansC. albicansInterkingdomphenolspolymicrobial biofilmS. aureussecreted aspartyl protease

Identifiers

PMID40755022
PMCPMC12344808

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.